/
INDEX.ST
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
InDex Pharmaceuticals Holding AB (publ)
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
www.flerie.com- Employees
- 4
- IPO / List date
- Oct 11, 2016
- HQ
- SE
Held by traders on TradeandTell
No one on the platform currently holds INDEX.ST.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in INDEX.ST as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded INDEX.ST yet.